We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Diagnostic Errors Lead to Inappropriate Antimicrobial Use

By LabMedica International staff writers
Posted on 01 Jun 2015
Print article
Image: An antibiogram showing a culture plate with different antibiotic discs and bacterial sensitivity (Photo courtesy of World Health Organization).
Image: An antibiogram showing a culture plate with different antibiotic discs and bacterial sensitivity (Photo courtesy of World Health Organization).
Misdiagnoses can lead to increased risk of incorrect antibiotic use, threatening patient outcomes and antimicrobial efficacy, while increasing healthcare costs.

All antimicrobial use establishes selective pressure that contributes to the relentless emergence of resistance in a broad array of pathogens and antimicrobial stewardship programs have been introduced to improve antimicrobial therapy, but in most cases improvements are modest.

Infectious disease specialists at the Minneapolis Veterans Affairs Health Care System, (Minnesota, MN, USA) and their university colleagues, conducted a retrospective cohort study at their Medical Center (MVAMC), evaluating 500 inpatient cases to examine provider diagnoses, categorized as either correct, indeterminate, incorrect, or a sign or symptom consistent with an infectious disease rather than a specific syndrome or disease, and to determine whether the antimicrobial course prescribed was appropriate.

The scientists found that 95% of patients with an incorrect or indeterminate diagnosis, or with a symptom identified but no diagnoses made, were given inappropriate antibiotics. By comparison, only 38% of patients who received a correct diagnosis were incorrectly given antibiotics. The inappropriate use of antibiotics contributes to antibiotic resistance, clinical failure, adverse drug events, and excessive costs. Additionally, they found that overall, only 58% of patients received a correct diagnosis, indicating that diagnostic errors were more prevalent in their study than in previous studies unrelated to antimicrobial use. The most common incorrect diagnoses identified by the specialists were pneumonia, cystitis, urinary tract infections, kidney infections and urosepsis.

The authors concluded that the impact of diagnostic accuracy on the appropriateness of antimicrobial therapy and they provide a detailed analysis of types and predictors of diagnostic errors and their relationship to types of inappropriate antimicrobial use. These findings suggest that more studies are needed to elucidate mechanisms of diagnostic errors related to antimicrobial prescribing. They also suggest that antimicrobial stewardship programs could increase their impact if they were designed to help providers make accurate initial diagnoses and to help providers know when antimicrobial therapy can be safely withheld.

Gregory A. Filice, MD, lead author of the study, said, “Diagnostic accuracy is integral to the safe use of antibiotics. In order to improve the use of antibiotics in healthcare, we must consider this challenge and look for tools and strategies that help clinicians decrease unnecessary and potentially harmful antibiotic use.” The study was published on May 18, 2015, in the journal Infection Control & Hospital Epidemiology

Related Links:
.
Minneapolis Veterans Affairs Health Care System 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.